Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The functional outcome and recovery of patients admitted to an intensive care unit following drug overdose: a follow-up study.

Anaesthesia and intensive care·2009
Same author

Traveller health: prevalence of diabetes, pre diabetes and the metabolic syndrome.

Irish medical journal·2009
Same author

The prevalence and distribution of Mycobacterium bovis infection in European badgers (Meles meles) as determined by enhanced post mortem examination and bacteriological culture.

Research in veterinary science·2009
Same author

Effects of estrogen therapy on age-related differences in gray matter concentration.

Climacteric : the journal of the International Menopause Society·2009
Same author

Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID).

Health technology assessment (Winchester, England)·2009
Same author

Entire genome sequences of two new HCV subtypes, 6r and 6s, and characterization of unique HVR1 variation patterns within genotype 6.

Journal of viral hepatitis·2009

Related Experiment Video

Updated: May 10, 2026

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

7.3K

Paediatric Cardiac Tumours: A National Population Study.

K Craig1, J Patel1, D Murphy2

  • 1Department of Paediatric Cardiology, Royal Hospital for Children, Glasgow, UK.

Pediatric Cardiology
|May 14, 2025
PubMed
Summary
This summary is machine-generated.

Paediatric cardiac rhabdomyomas, often linked to Tuberous Sclerosis Complex (TSC), are the most common heart tumors. Early identification and targeted therapies like mTOR inhibitors can improve outcomes for affected children.

Keywords:
Cardiac tumoursEchocardiographyPaediatricRhabdomyomasTuberous sclerosis

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K

Related Experiment Videos

Last Updated: May 10, 2026

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue
08:15

Isolation of Perivascular Multipotent Precursor Cell Populations from Human Cardiac Tissue

Published on: October 8, 2016

7.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K

Area of Science:

  • Cardiology
  • Genetics
  • Oncology

Background:

  • Paediatric cardiac tumours are rare, with rhabdomyomas being the most common, often associated with Tuberous Sclerosis Complex (TSC).
  • TSC is a genetic condition caused by variants in TSC1 or TSC2 genes, leading to potential cardiac complications like arrhythmias and obstructed blood flow.

Purpose of the Study:

  • To analyze the characteristics and outcomes of paediatric cardiac tumours over 23 years.
  • To investigate the association between tumour type, TSC, and clinical manifestations.
  • To evaluate the effectiveness of targeted therapies for benign cardiac tumours.

Main Methods:

  • A 23-year retrospective study of patients with cardiac tumours referred to the National Scottish Paediatric Cardiology service.
  • Analysis of tumour type, patient demographics, genetic associations (TSC1/TSC2), arrhythmias, and treatment modalities.
  • Statistical analysis to determine significant associations (e.g., rhabdomyomas in TSC, extra-cardiac symptoms).

Main Results:

  • 51 paediatric cardiac tumours identified; 93.6% were benign.
  • Rhabdomyomas were the most common tumour type overall and in patients with TSC (p = 0.000861).
  • 18% of benign tumours had documented arrhythmias, and TSC subtypes showed significant extra-cardiac symptom burden (p = 0.00105), especially TSC2-related renal and neurological issues.

Conclusions:

  • Paediatric cardiac rhabdomyomas, particularly those associated with TSC, require careful management due to potential complications.
  • Targeted therapies, including mTOR inhibitors for rhabdomyomas and beta-blockers for haemangiomas, are effective.
  • Genetic counselling for TSC families is crucial for understanding long-term morbidity and mortality risks, especially in TSC2 cases.